Cargando…
DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine
[Image: see text] Biomarker-driven drug selection plays a central role in cancer drug discovery and development, and in diagnostic strategies to improve the use of traditional chemotherapeutic drugs. DNA-modifying anticancer drugs are still used as first line medication, but drawbacks such as resist...
Autores principales: | Stornetta, Alessia, Zimmermann, Maike, Cimino, George D., Henderson, Paul T., Sturla, Shana J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379252/ https://www.ncbi.nlm.nih.gov/pubmed/27936622 http://dx.doi.org/10.1021/acs.chemrestox.6b00380 |
Ejemplares similares
-
DNA Adduct Profiles
Predict in Vitro Cell Viability
after Treatment with the Experimental Anticancer Prodrug PR104A
por: Stornetta, Alessia, et al.
Publicado: (2017) -
The use of an artificial nucleotide for polymerase-based recognition of carcinogenic O(6)-alkylguanine DNA adducts
por: Wyss, Laura A., et al.
Publicado: (2016) -
Influence of C-5 substituted cytosine and related nucleoside analogs on the formation of benzo[a]pyrene diol epoxide-dG adducts at CG base pairs of DNA
por: Guza, Rebecca, et al.
Publicado: (2011) -
Structural and biochemical impact of C8-aryl-guanine adducts within the NarI recognition DNA sequence: influence of aryl ring size on targeted and semi-targeted mutagenicity
por: Sproviero, Michael, et al.
Publicado: (2014) -
DNA adducts-chemical addons
por: Rajalakshmi, T. R., et al.
Publicado: (2015)